Nucleic Acid Testing Market 2015: Strategic Assessments of Leading Suppliers

April 2015 | 549 pages | ID: NE20A2B56FCEN
Venture Planning Group

Abstracts

This 549-page report presents an overview of the clinical significance and market needs for major current and emerging NAT assays, as well as extensive listings of companies developing and marketing innovative technologies and products. This report also presents strategic assessments of current and emerging suppliers of nucleic acid testing products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&&D, collaborative arrangements and business strategies.

Contains 549 pages and 22 tables

Contents

Microbiology/Infectious Diseases
  a. Overview
  b. Major Infectious Diseases
    AIDS
      Structure and Composition
      Classification
      AIDS Origins
      Animal Lentivirus Systems
      Virus Receptors
    HIV Infections in Humans
      Pathogenesis and Pathology
      CD4T Lymphocytes and Memory Cells
      Monocytes and Macrophages
      Lymphoid Organs
      Neural Cells
      Viral Coinfections
        Clinical Findings
      Plasma Viral Load
      Pediatric AIDS
        Neurologic Disease
        Opportunistic Infections
        Cancer
      Immunity
        Virus Isolation
        Serology
        Viral Nucleic Acid/Antigen Detection
      Epidemiology
        Worldwide Spread of AIDS
        United States
        Routes of Transmission
  DNA Probes
    Overview
        Quantitative PCR
        In Situ PCR
        Needed Improvements
  Viral Load/Drug Resistance Testing
  Genotype and Phenotype Testing
  Blood Banking Considerations
    Adenovirus
  Background
  Diagnostic Tests
  Vaccines and Drugs
  Adeno-Associated Viruses (AAV)
    Anthrax/Bacillus Anthracis
  Background
  Diagnostic Tests
  Vaccines and Drugs
    Babesiosis
  Background
    BEA and Other Bartonella Diseases
  Background
  Diagnostic Tests
  Vaccines and Drugs
    Chagas Disease
  Background
      Campylobacter
  Background
  Diagnostic Tests
    Culture Identification
  Vaccines and Drugs
    Chlamydia
  Background
    Chlamydia psittaci
    Chlmaydia pneumoniae
    Chlamydia trachomatis
  Diagnostic Tests
  Vaccines and Drugs
    Creutzfeldt-Jakob’s Disease
  Background
  Blood Transmission
  Diagnostic Tests
  Major Commercial and Academic Players
    Bayer
    Disease Sciences/Bio Tec Global
    Imperial College School of Medicine
    Ortho-Clinical Diagnostics
    Pall
    ProMetic Life Sciences
    Proteome Sciences/Idexx
    Q-One Biotech
    Serono
    U.S. Agricultural Research Service
  Drugs
  Vaccines
      Cytomegalovirus
  Background
    Chorioretinitis
    Gastrointestinal
    Central Nervous System Disease
  Diagnostic Tests
  Vaccines and Drugs
    Ebola Virus
  Background
    Epidemiology
    Clinical Syndromes
  Diagnostic Tests
  Vaccines and Drugs
      EchoVirus
  Background
    Acute Aseptic Meningitisis
    Encephalitis
    Exanthems
    Respiratory Disease
    Myopericarditis
    Neonatal Infections
  Diagnostic Tests
  Vaccines and Drugs
    Encephalitis
  Background
  Diagnostic Tests
  Vaccines and Drugs
      Enteroviruses
  Background
  Diagnostic Tests
    Viral Isolation and Identification
    Antibody Tests
  Vaccines and Drugs
      Epstein-Barr Virus
  Background
  Diagnostic Tests
  Vaccines and Drugs
      Gonorrhea
  Background
  Diagnostic Tests
  Vaccines and Drugs
    Hepatitis
  Hepatitis A
  Hepatitis B
    Structure and Composition
    Replication
  Hepatitis C
  Hepatitis D (Delta)
  Hepatitis E
  Hepatitis G
  Hepatitis Infections Pathology
  Clinical Findings
  Laboratory Tests
    Hepatitis A
    Hepatitis B
    Hepatitis C
    Hepatitis D
    Hepatitis E
  Virus-Host Immune Reactions
  Epidemiology
    Hepatitis A
    Hepatitis B
    Hepatitis C
    Hepatitis D (Delta)
  Vaccines and Drugs
      Herpes Simplex Virus
  Background
  Diagnostic Tests
  Vaccines and Drugs
    Legionella
  Background
  Diagnostic Tests
  Vaccines and Drugs
    Lyme Disease
  Background
    Clinical Description
    Clinical Case Definition
    Laboratory Criteria for Diagnosis
    Case Classification
  Diagnostic Tests
  Vaccines and Drugs
    Malaria
      Mycoplasma
  Background
    Ureaplasma Urealyticum & Mycoplasma
    Hominis
  Diagnostic Tests
  Vaccines and Drugs
    Papillomaviruses/HPV
  Background
  #HPV in Cancer
    Cervical Neoplasm
  Diagnostic Tests
  Vaccines and Drugs
    Prevention
    Parvovirus B19
  Background
    Microbiology
    Epidemiology
    Clinical Syndromes
    Erythema Infectiosum (Slapped Cheek)
    Adult Polyarthropathy
    Transient Aplastic Crisis
    Transient Pancytopenia
    Red Cell Aplasia in Immunocompromised
    Perinatal Infections
  Diagnostic Test
  Vaccines and Drugs
    Pneumonia
  Background
  Diagnostic Tests
  Vaccines and Drugs
      Polyomaviruses
  Background
  Diagnostic Tests
  Vaccines and Drugs
  #Salmonellosis
  Background
  Diagnostic Tests
  Vaccines and Drugs
    Shigellosis
  Background
  Diagnostic Tests
  Vaccines and Drugs
    Streptococci
  Background
    Diagnostic Tests
    Vaccines and Drugs
      Group A Streptococci
      Group B Streptococci
        Toxoplasmosis
    Background
    Diagnostic Tests
    Vaccines and Drugs
        Tuberculosis
    Background
    Diagnostic Tests
      Microscopic Characteristics
      Cultural Characteristics
      Skin Tests
      MDRTB
    Vaccines and Drugs
      West Nile Virus
    Background
      Clinical Syndromes
    Diagnostic Tests
    Vaccines and Drugs
      Yersinia
    Background
    Diagnostic Tests
    Vaccines and Drugs
        Antibiotic Susceptibility
Cancer Testing
  a. Overview
  b. Major Cancer Types
      Prostate
      Lung
      Colon and Rectum
    Breast
      Skin
    Uterine
    Leukemia
      Oral
    c. Oncogenes
    Abl/abl-bcr
    AIB1
    BCL-2
    BRCA1
    CD44
    C-fos
    C-myb
    C-myc
    CYP17
    Erb-B
    HPC1
    N-myc
    P40
    P51
    P53
    PIK3CA
    PTI-1
    Ras
    Reg
    Sis
    Src
Genetic Diseases
  a. Overview
  b. Nucleic Acid Amplification
  c. Chromosome Imaging
  d. Genomics Technologies
  e. Proteomics Technologies
  f. Current Pharmacogenomic Tests
  g. Future Pharmacogenomic Testing
  h. Major Diseases
      Achondroplasia
        Autosomal Dominant Polycystic Kidney Disease
        Cancer
        Cosmetogenomics
        Cystic Fibrosis
      Down's Syndrome
      Duchenne and Becker Muscular Dystrophy
        Factor V (Leiden)
        Factor IX Deficiency
        Fragile X Syndrome
        Heart Disease
        Hemochomatosis
        Hemophilia
        Huntington's Disease
        Maternal-Fetal Incompatibility
        Multiple Endocrine Neoplasia
        Phenylketonuria (PKU)
        Polycystic Kidney Disease (PKD)
        Prenatal Screening
        Retinitis Pigmentosa
        Retinoblastoma
        Sickle Cell Anemia
        Spinal Muscular Atrophy
        Vitamin B12 Metabolism
  i. Social Issues and Concerns
Forensic Testing
  a. Overview
  b. Multilocus and Single Locus Probes
        Multilocus Probes
        Single Locus Probes
        PCR and RFLP
  c. The FBI
  d. DNA Profile Data Banks
        U.S.A.
        U.K.
  e. Judicial Implementation
  f. Major Crime Categories
  g. Factors Contributing to the DNA Probe Market Expansion
        Technology Availability
        Use of Hair as Evidence
  h. Wildlife Forensics
Paternity Testing/HLA Typing
Other Applications
  a. Disease Susceptibility Testing
  b. Cardiovascular Diseases
  c. Diabetes
  d. Alzheimer's Disease
  e. Periodontal Disease
  f. Plasma Purification
  g. Organ Transplantation
  h. Water Contamination
  i. Other

COMPETITIVE PROFILES

Abbott
Affymetrix
Agilent
Applied Gene Technologies
Arca
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
Biotest
Caliper
Cepheid
Decode
Diadexus
Eiken
Enzo
Exact Sciences
Fujirebio
Gen-Probe
Hologic
Illumina
Innogenetics/Solvay
Kreatech
Li-Cor Biosciences
Life Technologies
Monogram Biosciences
Myriad Genetics
Nanogen/Elitech
Novartis
Orchid CellMark
Ortho-Clinical Diagnostics
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens
Sierra Molecular
Takara Bio
Tecan Group

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing AIDS Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Herpes Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Legionella Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Papilloma Virus Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Shigella Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic And Other Direct Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Test For Genetic Diseases